EAGLE PHARMS INC earned $2.73 per diluted share in fiscal year 2022. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to $0.91 per diluted share. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters EAGLE PHARMS INC has filed alongside them.
FY2022 annual
EPS (Diluted)$2.73
YoYn/m
5Y CAGR-3.5%
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2023, ended Jun 30, 2023ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
EGRX EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was EAGLE PHARMS INC's diluted earnings per share in fiscal year 2022?
EAGLE PHARMS INC earned $2.73 per diluted share in fiscal year 2022.
How fast is EAGLE PHARMS INC's diluted earnings per share growing?
EAGLE PHARMS INC (EGRX) reported a loss of $0.66 per diluted share in fiscal year 2021 and $2.73 per diluted share in fiscal year 2022. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is EAGLE PHARMS INC's diluted earnings per share over the last twelve months?
EAGLE PHARMS INC (EGRX) reported $0.91 per diluted share over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
How has EAGLE PHARMS INC's diluted earnings per share changed over the years?
Across the 11 fiscal years this page covers, EAGLE PHARMS INC (EGRX) diluted earnings per share went from -$14.11 in fiscal year 2012 to $2.73 in fiscal year 2022.
What was EAGLE PHARMS INC's diluted earnings per share in the most recent quarter?
EAGLE PHARMS INC (EGRX) reported $0.39 in diluted earnings per share in Q2 2023. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what EAGLE PHARMS INC (EGRX) reported on that line in every period on record.
